The companies said on Tuesday that Danaher will pay $180 per share to buy Masimo. The offer represents a premium of 38.3% to Masimo's last close.

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available ...

Masimo Corporation MASI recently announced the FDA clearance of its Masimo SET-powered MightySat Medical Pulse Oximeter, available Over-The-Counter (OTC) to consumers without a prescription. This ...

Masimo iSpO2 pulse oximeter and the iSpO2 app. Manufactured and submitted by Masimo Corp. (Irvine, CA). The iSpO2 is a measure-through-motion and low-perfusion pulse oximeter made for iPhone and iPad.

Wearable devices have become essential to clinical research, as they enable research studies to collect health-related data on patients around the clock. These devices, which includes commercial ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of the Rad-G™ Pulse Oximeter, a rugged handheld device that provides clinically proven SET ® pulse oximetry, ...

This morning medical device company Masimo announced FDA clearance for the measurement of respiration rate from a photoplethysmogram (RRp), so that it may now be used on the MightSat Rx finger pulse ...

Apple on Thursday began selling revised models of the Apple Watch Series 9 and Ultra 2 in the US without the blood oxygen feature as the company faces a patent dispute with medical company Masimo. In ...

Joe Kiani, Founder and CEO of Masimo, said, “Until now, consumers and even healthcare providers had no way of knowing what pulse oximeter they could trust to use at home. On the internet and even in ...

Feb 17 (Reuters) - Danaher, ⁠a $150 ⁠billion U.S. company that makes ⁠tools used in developing and testing medicines, on Tuesday agreed to buy Masimo for $9.9 billion, expanding in patient-monitoring ...